Question 1

Who are the top researchers at Glucox Biotech (Sweden)?

Accepted Answer

Ranked on the quality score, Per Wikström lead among researchers whose main affiliation is Glucox Biotech (Sweden).

Question 2

What are the most cited papers from Glucox Biotech (Sweden)?

Accepted Answer

The most cited paper from Glucox Biotech (Sweden) is "The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice" (Enayat Anvari, Pernilla Wikström, Erik Walum et al., 2015), with 101 citations. Next come "The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro" (74) and "Shikonin Increases Glucose Uptake in Skeletal Muscle Cells and Improves Plasma Glucose Levels in Diabetic Goto-Kakizaki Rats" (48).

Question 3

Which research topics does Glucox Biotech (Sweden) publish most on?

Accepted Answer

By volume in 2022-now: Retinal Diseases and Treatments, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Retinal Development and Disorders and Pancreatic function and diabetes.

Question 4

Which fields of science does Glucox Biotech (Sweden) work in?

Accepted Answer

In all years, 53% of research at Glucox Biotech (Sweden) is in Life Sciences, 38% in Health Sciences. Its largest fields are Medicine (37%), Biochemistry, Genetics and Molecular Biology (32%), Immunology and Microbiology (16%). It does 1.6× the world's share of Life Sciences.

Question 5

Is Glucox Biotech (Sweden)'s research output growing?

Accepted Answer

Output in 2022-2025 was 3% lower than in 2018-2021.